Navigating the Challenges of Exome Sequencing in Structurally Normal Fetuses.

Sylvie Langlois, Lyn S Chitty
Author Information
  1. Sylvie Langlois: Department of Medical Genetics, University of British Columbia, Vancouver, Canada. ORCID
  2. Lyn S Chitty: North Thames Genomic Laboratory Hub, Great Ormond Street Hospital for Children NHS Foundation Trust, London, UK. ORCID

Abstract

No abstract text available.

References

  1. S. Drury, H. Williams, N. Trump, et al., ���Exome Sequencing for Prenatal Diagnosis of Fetuses With Sonographic Abnormalities,��� Prenatal Diagnosis 35, no. 10 (2015): 1010���1017, https://doi.org/10.1002/pd.4675.
  2. R. Mellis, K. Oprych, E. Scotchman, M. Hill, and L. S. Chitty, ���Diagnostic Yield of Exome Sequencing for Prenatal Diagnosis of Fetal Structural Anomalies: A Systematic Review and Meta���Analysis,��� Prenatal Diagnosis 42, no. 6 (2022): 662���685, https://doi.org/10.1002/pd.6115.
  3. R. Sukenik���Halevy, S. Perlman, N. Ruhrman���Shahar, et al., ���The Prevalence of Prenatal Sonographic Findings in Postnatal Diagnostic Exome Sequencing Performed for Neurocognitive Phenotypes: A Cohort Study,��� Prenatal Diagnosis 42, no. 6 (2022): 717���724, https://doi.org/10.1002/pd.6095.
  4. M. Levy, S. Lifshitz, M. Goldenberg���Fumanov, et al., ���Exome Sequencing in Every Pregnancy? Results of Trio Exome Sequencing in Structurally Normal Fetuses,��� Prenatal Diagnosis 45, no. 3 (2025): 276���286, https://doi.org/10.1002/pd.6585.
  5. Z. Gao, X. Zhu, H. Ren, Y. Wang, C. Hua, and X. Kong. ���Prenatal Exome Sequencing for Morphologically Normal Fetus: Should We be Doing It?,��� Prenatal Diagnosis 45, no. 3 (2025): 287���293, https://doi.org/10.1002/pd.6624.
  6. N. Chandler, M. Holder���Espinasse, and F. Mone, ���The Challenges of Performing Exome Sequencing in Structurally Normal Fetuses,��� Prenatal Diagnosis 45, no. 3 (2025): 294���298, PMID: 39394633, https://doi.org/10.1002/pd.6687.
  7. D. J. Amor, L. S. Chitty, and I. B. Van den Veyver, ���Current Controversies in Prenatal Diagnosis 2: The 59 Genes ACMG Recommends Reporting as Secondary Findings When Sequencing Postnatally Should be Reported When Detected on Fetal (and Parental) Sequencing,��� Prenatal Diagnosis 40, no. 12 (2020): 1508���1514, https://doi.org/10.1002/pd.5670.
  8. D. Vears and D. J. Amor, ���A Framework for Reporting Secondary and Incidental Findings in Prenatal Sequencing: When and for Whom?,��� Prenatal Diagnosis 42, no. 6 (2022): 697���704, https://doi.org/10.1002/pd.6097.
  9. E. Harding, J. Hammond, L. S. Chitty, M. Hill, and C. Lewis, ���Couples Experiences of Receiving Uncertain Results Following Prenatal Microarray or Exome Sequencing: A Mixed���Methods Systematic Review,��� Prenatal Diagnosis 40, no. 8 (2020): 1028���1039, https://doi.org/10.1002/pd.5729.
  10. H. McInnes���Dean, R. Mellis, M. Daniel, et al., ���Something That Helped the Whole Picture': Experiences of Parents Offered Rapid Prenatal Exome Sequencing in Routine Clinical Care in the English National Health Service,��� Prenatal Diagnosis 44, no. 4 (2024): 465���479, https://doi.org/10.1002/pd.6537.
  11. K. Wou, T. Weitz, C. McCormack, et al., ���Parental Perceptions of Pre���Natal Whole Exome Sequencing (PPPWES) Study,��� Prenatal Diagnosis 38, no. 11 (2018): 801���811, https://doi.org/10.1002/pd.5332.
  12. D. Brabbing���Goldstein, L. Bazak, N. Ruhrman���Shahar, et al., ���Potentially Missed Diagnoses in Prenatal Versus Postnatal Exome Sequencing in the Lack of Informative Phenotype: Lessons Learned From a Postnatal Cohort,��� Prenatal Diagnosis 44, no. 12 (2024): 1423���1434, https://doi.org/10.1002/pd.6659.
  13. L. Hui, E. Szepe, J. Halliday, and C. Lewis, ���Maternity Health Care Professionals' Views and Experiences of Fetal Genomic Uncertainty: A Review,��� Prenatal Diagnosis 40, no. 6 (2020): 652���660, https://doi.org/10.1002/pd.5673.
  14. C. Lewis, J. Hammond, J. E. Klapwijk, et al., ���Dealing With Uncertain Results From Chromosomal Microarray and Exome Sequencing in the Prenatal Setting: An International Cross���Sectional Study With Healthcare Professionals,��� Prenatal Diagnosis 4, no. 6 (2021): 720���732, https://doi.org/10.1002/pd.5932.
  15. N. J. Chandler, E. Scotchman, R. Mellis, V. Ramachandran, R. Roberts, and L. S. Chitty, ���Lessons Learnt From Prenatal Exome Sequencing,��� Prenatal Diagnosis 42, no. 7 (2022): 831���844, https://doi.org/10.1002/pd.6165.
  16. R. Zemet and I. B. Van den Veyver, ���Impact of Prenatal Genomics on Clinical Genetics Practice,��� Best Practice & Research Clinical Obstetrics & Gynaecology 97 (2024): 102545, https://doi.org/10.1016/j.bpobgyn.2024.102545.
  17. M. Duyzend, M. Sud, A. M. D���Gama, T. Poorvu, J. Estroff, and M. H. Wojcik, ���Going Back in Time: Prenatal Presentations of Postnatal Genetic Diagnoses Made in a Neonatal Intensive Care Unit,��� Prenatal Diagnosis (2024), Online ahead of print, https://doi.org/10.1002/pd.6710.
  18. M. H. Duyzend, P. Cacheiro, J. O. B. Jacobsen, et al., ���Improving Prenatal Diagnosis Through Standards and Aggregation,��� Prenatal Diagnosis 44, no. 4 (2024): 454���464, https://doi.org/10.1002/pd.6522.
  19. F. Dhombres, P. Morgan, B. P. Chaudhari, et al., ���PN Prenatal Phenotyping: A Community Effort to Enhance the Human Phenotype Ontology,��� American Journal of Medical Genetics Part C: Seminars in Medical Genetics 190, no. 2 (2022): 231���242, https://doi.org/10.1002/ajmg.c.31989.
  20. L. S. Chitty and I. B. Van den Veyver, ���Facilitating Variant Curation Sharing for Fetal Precision Genomics: A New Venture for Prenatal Diagnosis,��� Prenatal Diagnosis 42, no. 12 (2022): 1479���1480, https://doi.org/10.1002/pd.6252.
  21. J. L. Giordano and R. J. Wapner, ���The Fetal Sequencing Consortium: The Value of Multidisciplinary Dialog and Collaboration,��� Prenatal Diagnosis 42, no. 7 (2022): 807���810, https://doi.org/10.1002/pd.6190.
  22. S. Richards, N. Aziz, S. Bale, et al., ���Standards and Guidelines for the Interpretation of Sequence Variants: A Joint Consensus Recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology,��� Genetics in Medicine 17 (2015): 405���424.
  23. E. R. Riggs, E. F. Andersen, A. M. Cherry, et al., ���Technical Standards for the Interpretation and Reporting of Constitutional Copy���Number Variants: A Joint Consensus Recommendation of the American College of Medical Genetics and Genomics (ACMG) and the Clinical Genome Resource (ClinGen),��� Genetics in Medicine 22, no. 2 (2020): 245���257, https://doi.org/10.1038/s41436���019���0686���8.
  24. M. Durkie, E. J. Cassidy, I. Berry, et al. ACGS Best practice Guidelines for Variant Classification in Rare Disease 2024. The Association for Clinical Genomic Science, Accessed February 18, 2025, http://www.acgs.uk.com/media/12533/uk���practice���guidelines���for���variant���classification���v12���2024.pdf.

Word Cloud

Created with Highcharts 10.0.0NavigatingChallengesExomeSequencingStructurallyNormalFetuses

Similar Articles

Cited By